UPDATE: CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-3 & PURE CANNABIDIOL (“CBD”) FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE
July 14, 2020 11:04 ET
|
CanaQuest Medical Corp
TORONTO, July 14, 2020 (GLOBE NEWSWIRE) -- CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the "Company" or “CanaQuest”), a company developing unique health products and nutraceuticals utilizing...
CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-3 & PURE CANNABIDIOL (“CBD”) FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE
July 14, 2020 09:00 ET
|
CanaQuest Medical Corp
TORONTO, July 14, 2020 (GLOBE NEWSWIRE) -- CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the "Company" or “CanaQuest”), a company developing unique health products and nutraceuticals utilizing...
Endonovo Therapeutics Announces Positive 2019 Fiscal Results
May 04, 2020 08:15 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, May 04, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today reported financial results for fiscal year ended December 31, 2019. ...
Endonovo Therapeutics Introduces Support of SofPulse® With A New Ancillary Multi-Use Patient Brace From Protex
February 24, 2020 13:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced the production and introduction of an ancillary multi-use...
RespireRx Pharmaceuticals Inc. CEO Issues Progress and Status Report
February 12, 2020 09:15 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Feb. 12, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), a leader in the development of medicines for respiratory disorders and central nervous system (“CNS”)...
Endonovo Therapeutics Reports Third Quarter 2019 Results
November 19, 2019 16:35 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today its financial results for the quarter ended September 30,...
Endonovo Partners with Veterans Healthcare Supply Solutions, Appoints Samir Awad, M.D., to Scientific Advisory Board
September 09, 2019 09:00 ET
|
Endonovo Therapeutics Inc.
LOS ANGELES, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical® therapeutic...
ReNetX Bio Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of Fusion Protein AXER-204
August 14, 2019 09:02 ET
|
ReNetx Bio
NEW HAVEN, Conn., Aug. 14, 2019 (GLOBE NEWSWIRE) -- ReNetX Bio, Inc., a leading biotechnology company committed to reversing disease and damage for patients suffering from central nervous system...
EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl NEWSFLASH
July 22, 2019 10:51 ET
|
LGC Capital LTD.
MONTRÉAL, July 22, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) is pleased to announce that it has paid the 2nd Tranche, as contractually agreed, in acquiring...
Digital Therapeutics Market To Reach USD 0.89 Billion By 2026 | Reports And Data
July 16, 2019 09:58 ET
|
Reports and Data
New York, July 16, 2019 (GLOBE NEWSWIRE) -- The rising awareness, research and development, technological advancements and launch of novel products with enhanced efficiency are the key factors...